Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-15.56	9.78	11.58
Graham Fair Price	293.90	2.82	0.72
PEG	-99.56	< 0.005	0.81
Price/Book	1.21	0.37	0.36
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	-93.24	5.74	-84.95
Price/Sales	1.93	0.68	0.67
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-76.89	0.05	0.23
Operating Margin	287.55	0.07	0.02
ROA	1382.78	< 0.005	< 0.005
ROE	< 0.005	0.02	1398.30
ROIC	< 0.005	0.01	28.40
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.08	-0.04	85.10
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.75	2.90	287.35
EPS QOQ	-1.05	16.29	1452.50
FCF QOQ	-1.00	0.00	inf
Revenue QOQ	0.02	< 0.005	-68.35
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	14.86	11.80	-20.61
Days Sales Outstanding (DSO)	117.88	110.04	-6.65
Inventory Turnover	6.06	7.63	25.96
Debt/Capitalization	0.43	0.50	17.30
Quick Ratio	0.57	0.56	-2.45
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	4.63	4.71	1.76
Cash	0.16	0.15	-7.95
Capex	0.00	n.A.	n.A.
Free Cash Flow	0.00	n.A.	n.A.
Revenue	2.49	2.51	1.04
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.63	0.70	10.27
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.32	7.13	-14.29
Naive Interpretation	Member

06 - Financial Health · Bad

Rating